Azelis enters into new distribution agreement with GELITA in France

Press Release from Azelis Americas CASE

Azelis is proud to announce its new exclusive distribution agreement with GELITA, a global leader in the production of gelatin and collagen products. Azelis will be entrusted with the distribution activities for all gelatin products for the pharmaceutical and nutraceutical industries in France. 

Highlights & rationale

The new mandate covers GELITA’s full gelatin range for the pharmaceutical and nutraceutical industry in France.

This new mandate is the first-ever partnership between Azelis and GELITA.

GELITA awarded this mandate to Azelis, based on its market position and its extensive knowledge of the pharma and nutraceuticals industry.

This partnership is in line with Azelis’ strategy to complement its lateral value chain offerings with innovative products from new or existing principals.

GELITA is a manufacturer of gelatin and collagen peptides for the food, health & nutrition and pharmaceutical industries. Gelatin is a safe, highly biocompatible and flavorless ingredient that is commonly used due to its unique versatility in food, medications and vitamin capsules. Gelatin, being a pure protein, offers several advantages demanded by today’s consumer as it is non-allergenic, natural sourced and GMO-free. GELITA differentiates itself by being more than just a supplier of gelatin and collagen products. They are a provider of innovations and overall solutions so that their customers can obtain that decisive competitive advantage in respective markets.

The Azelis France Pharma team has gained GELITA’s trust due to its large customer base, its complementary portfolio offerings and the high standards when it comes to customer service. Azelis’ large customer network within the pharmaceutical market segment will prove to be of great value whilst building new business for GELITA’s gelatin portfolio.

Matthew Dickman, Market Segment Director for Pharma EMEA at Azelis, comments:

“This new distribution agreement enables us to offer innovative, tailor-made solutions to the Azelis pharmaceutical markets in France. The GELITA gelatin product portfolio is very complementary with our current pharma product range in France, and we’re delighted to start providing it to our customers.”

Didier Peycelon, Sales Director Pharma Europe at GELITA, adds:

“We chose Azelis to distribute our pharmaceutical gelatin products in France because their teams are highly qualified, skilled and professional. With a good knowledge of the market, great customer intimacy as well as their professional standards, GELITA will rely on Azelis as a new partner to develop our sales on the French market.”

With more than 60 application labs across the world, each dedicated to a market segment, Azelis provides technical support to customers and suppliers. Azelis Pharma has three labs located in the UK, Germany and in Canada, which are staffed by skilled industry chemists and formulators. Each lab provides elaborate and professional formulation solutions and technical support to customers.

Companies Mentioned in this Press Release: